On-Demand Webinars

1. FDA Guidance: Inspection Of Injectable Products For Visible Particulate

   A review of the draft guidance and importance of component selection as it relates to establishing a risk-based approach and the role of the NovaPure product line in component selection.

2. Scaling Up A Revolutionary Amorphous Solid Dispersion Platform 3/19/2024

   Process parameter and quality attribute relationships, including those for typical pre- and post-ASD unit operations, will be explored in the context of real-world examples.

3. Navigating Your Holistic Approach To CCI For Biologic Drug Products 6/12/2024

   Explore regulatory framework and expectations, and see the benefit of a comprehensive approach to CCI tailored for mAbs and complex modalities such as fusion proteins or bioconjugates.

4. How To Deal With The Complexity Of Drugs In Clinical Development

   Discover how to advance new compounds with complex chemistry through each stage of development by refining processes to give fit-for-purpose manufacturability and yields.

5. Continuous Flow Techniques For Fine Chemical Manufacturing

   Explore the advantages and challenges of continuous flow processes and the concept of mini-monoplant technology, along with examples that demonstrate the versatility of continuous processing.

6. Managing Risks In Injectable Drug Delivery 3/13/2025

   Gain insights pertinent to efficient and effective drug development. Understand and execute a risked-based critical thinking approach related to injectable drug packaging and delivery.

7. Challenges With Pediatric Flavors For Taste Enhancement And Modulation 3/17/2022

   Taste masking for children can present unique challenges for drug developers. Learn how we can use flavor, not just to provide a desired taste, but also to provide taste masking.

8. Formulating Better ASDs And mAbs: Advances In Applied Nanotechnology 5/1/2024

   Learn about new data on nanotechnology formulations for multiple dose forms and routes of delivery, including oral, long-acting injectables, inhalation, and ophthalmic.

9. Key Considerations When Developing Your Combination Product 2/20/2024

   Succeed in combination product development by understanding the risk factors that may arise and implementing mitigation strategies that will streamline the device development process.

10. Nanoparticle Enabled Formulation And Drug Delivery Solutions

    Discover how revolutionary and environmentally sustainable nanoparticle technologies coupled with innovative formulation approaches can address drug solubility issues and add value for patients.